Bull & Bear

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the cyclical setup (book-to-bill 1.10 against a trough 12.7% operating margin) is genuinely asymmetric and the Q4 FY2026 snapback to an 18.5% margin is already on the tape, but management's hold-then-cut guidance history means the November 2026 1H print should govern sizing rather than today's price.

The single most important tension is whether FY2026's 340bp gross-margin reset is transitory first-unit cost (Bull) or a structural mix-down to a 12–14% through-cycle margin (Bear). Both sides converge on the same observable to settle it — 1H FY2027 gross margin above 37% (Bull confirm) or below 35% (Bear confirm). The secondary debate — whether AI/HBM capex bypasses molding into bonders — is real, multi-year, and unlikely to be resolved in the 12–18 month window, which is why it sets the multiple ceiling more than the directional call.

Bull Case

Bull target: ¥4,200 over 12–18 months. Method: FY2028 normalized OP of ¥12B (FY27 guide ¥10.2B plus INNOMS ramp and PLP volumes), EPS roughly ¥120, applied at 35x P/E — within the FY2024 cycle-recovery multiple of 41x. Cross-check: ~22x EV/mid-cycle EBIT plus ¥11B net cash equals ¥3,660 base, with the remaining gap covered by confirmed INNOMS pricing. The single most important catalyst is the 1H FY2027 print (November 2026) showing gross margin rebuilding above 37% on rising HBM and PLP volume. Disconfirming signal: 1H FY2027 gross margin stuck below 35% on a rising-volume base, which would confirm the FY26 compression is structural and force a mid-cycle margin framework down to ~13%.

Bear Case

Bear downside target: ¥1,800 over 12–18 months (~30% downside from ¥2,579). Method: assume FY27 OP prints ¥7B vs ¥10.24B guide (the same shape as the FY25 and FY26 misses), net income ~¥5B, EPS ~¥66, applied at 27x P/E (compressed from 42x as the recovery narrative breaks). Cross-checks: Morgan Stanley sits at ¥2,100 already; bear quant scenario (¥7B OP × 15x P/E) implies ¥1,850. Primary trigger: 1H FY2027 gross margin printing below 35% in November 2026, OR a Q3 FY2027 (February 2027) guidance cut on the same hold-then-cut pattern. Cover signal: 1H FY2027 gross margin of 37%+ with operating margin 16%+ and positive FCF, OR a named tier-1 HBM compression unit win at confirmed +20%+ INNOMS ASP premium.

The Real Debate

Verdict

Lean Long, Wait For Confirmation. Bull carries more weight in the 12–18 month window because the cyclical math (book-to-bill 1.10 against trough operating margin) is genuinely asymmetric and Q4 FY2026's 18.5% operating margin is a print, not a forecast — it directly contradicts the structural-mix interpretation if the order book translates as backlog mechanics suggest. The single most important tension is the margin-reset debate, and both advocates name the same observable to settle it: the 1H FY2027 gross margin in November 2026 (Bull needs above 37%, Bear needs below 35%). Bear could still be right because management has held-then-cut three consecutive single-year guides and the AI-capex-flows-to-bonders critique is structurally durable enough to cap the multiple even if the cyclical recovery lands. The verdict changes to Lean Long outright if 1H FY2027 gross margin prints above 37% on rising HBM and PLP volume; it changes to Avoid if margin prints below 35% on the same rising-volume base, or if Q3 FY2027 (February 2027) repeats the hold-then-cut pattern. The durable thesis breaker — what actually decides the next five years — is whether INNOMS lands its first commercial order at the targeted +20–30% ASP premium; the November 2026 print is the near-term evidence marker that gates the position size, not the long-run business question.